Matches in Wikidata for { <http://www.wikidata.org/entity/Q95799599> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q95799599 description "clinical trial" @default.
- Q95799599 description "ensayo clínico" @default.
- Q95799599 description "ensayu clínicu" @default.
- Q95799599 description "klinisch onderzoek" @default.
- Q95799599 description "клінічне випробування" @default.
- Q95799599 description "临床试验" @default.
- Q95799599 name "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 name "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 type Item @default.
- Q95799599 label "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 label "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 prefLabel "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 prefLabel "Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma" @default.
- Q95799599 P1050 Q95799599-4A79C911-DE0B-400F-937D-31999542CB59 @default.
- Q95799599 P1050 Q95799599-C4C62C0F-E82C-45CC-AAA5-A1237973ABE3 @default.
- Q95799599 P1132 Q95799599-D76BC3D5-0A11-46A3-8995-EF9A0922CD86 @default.
- Q95799599 P1476 Q95799599-D15B5957-3A72-40E6-946D-AB817B8BC436 @default.
- Q95799599 P17 Q95799599-09ED82C0-2904-4D84-83EB-D38D58323C16 @default.
- Q95799599 P2899 Q95799599-1C78B401-37C2-45B3-9BB8-6E75A72B0BE7 @default.
- Q95799599 P3098 Q95799599-91091752-5F96-4EA1-BE67-2AE1BC30D6C6 @default.
- Q95799599 P31 Q95799599-68775AB3-887D-45A3-B290-90E28BA093CE @default.
- Q95799599 P4844 Q95799599-75659D42-6323-48A6-AEBB-B2063B5C1C33 @default.
- Q95799599 P4844 Q95799599-AF15EBD4-83E9-443B-A933-7CB3C3C46999 @default.
- Q95799599 P4844 Q95799599-C934F01E-C0D5-4456-A5D6-A4282D51B19B @default.
- Q95799599 P4844 Q95799599-E1EE5679-5E5B-4F59-A9C7-3558BFFC99CB @default.
- Q95799599 P580 Q95799599-688C968C-1AC7-435E-98DA-5C0E62DA308D @default.
- Q95799599 P582 Q95799599-12620BBB-D1C5-43B0-8FA2-E86D2F2EA6A5 @default.
- Q95799599 P6099 Q95799599-2C80ADBA-1E59-4B59-ACF5-4E865AD15655 @default.
- Q95799599 P6099 Q95799599-4CFCA483-9AC8-4F9C-A94B-333462B833E0 @default.
- Q95799599 P767 Q95799599-952ACB38-BF61-469F-A6BE-B53A57A45BE3 @default.
- Q95799599 P8005 Q95799599-57EF1C79-5C26-417D-A950-B289245259BE @default.
- Q95799599 P8363 Q95799599-516717DF-1C79-44AB-9743-BC830B4646A1 @default.
- Q95799599 P859 Q95799599-25DB0BBE-273C-4110-B20D-F3BD50FA0161 @default.
- Q95799599 P1050 Q180614 @default.
- Q95799599 P1050 Q2453464 @default.
- Q95799599 P1132 "+100" @default.
- Q95799599 P1476 "Treatment of Immune Checkpoint Inhibitor-Related Colitis With Infliximab or Vedolizumab: A Randomized Trial" @default.
- Q95799599 P17 Q30 @default.
- Q95799599 P2899 "+18" @default.
- Q95799599 P3098 "NCT04407247" @default.
- Q95799599 P31 Q30612 @default.
- Q95799599 P4844 Q20801760 @default.
- Q95799599 P4844 Q415264 @default.
- Q95799599 P4844 Q66559285 @default.
- Q95799599 P4844 Q7918002 @default.
- Q95799599 P580 "2020-06-30T00:00:00Z" @default.
- Q95799599 P582 "2021-12-31T00:00:00Z" @default.
- Q95799599 P6099 Q42824440 @default.
- Q95799599 P6099 Q5452194 @default.
- Q95799599 P767 Q664846 @default.
- Q95799599 P8005 Q76649614 @default.
- Q95799599 P8363 Q78089383 @default.
- Q95799599 P859 Q1525831 @default.